NDC11 00054027803
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00054-0278-03 | 00054-0278 |
| 00054-0278-3 | 00054-0278 |
| 00054-278-03 | 00054-278 |
| 0054-0278-03 | 0054-0278 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naratriptan | NARATRIPTAN | Hikma Pharmaceuticals USA Inc. | fd1944b3-8054-4faa-a82e-d818dfdd3875 | 2023-03-03 | Warnings, Adverse reactions | 0054-0278-03 0054-0278 00054027803 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.